Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Prevalence and Risk Factors Nocturnal Polyuria in Female OAB

NCT03810027 ·Status: COMPLETED

Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes

NCT07025642 ·Status: RECRUITING ·Phase: NA

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

NCT04023253 ·Status: UNKNOWN ·Phase: PHASE3

The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial

NCT07114640 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

NCT05040984 ·Status: UNKNOWN

Herbal Patch for Overactive Bladder

NCT03532789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy

NCT07337252 ·Status: COMPLETED

Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.

NCT01282840 ·Status: COMPLETED ·Phase: NA

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

NCT03807024 ·Status: COMPLETED

Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

NCT03059134 ·Status: COMPLETED ·Phase: PHASE3

Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study

NCT05946902 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity

NCT06197295 ·Status: RECRUITING ·Phase: PHASE4

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker

NCT04693897 ·Status: UNKNOWN

Bladder Diary for Diagnosing Bladder Oversensitivity

NCT04981015 ·Status: COMPLETED

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

NCT01533597 ·Status: COMPLETED ·Phase: PHASE4

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

NCT03572231 ·Status: COMPLETED

Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

NCT01729819 ·Status: COMPLETED ·Phase: PHASE2

A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden

NCT03903094 ·Status: COMPLETED

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients

NCT01223937 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)

NCT00902265 ·Status: COMPLETED

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women

NCT01684800 ·Status: COMPLETED ·Phase: PHASE2

Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes

NCT02540707 ·Status: COMPLETED ·Phase: PHASE4

Predictors for Retreatement of OAB After DC Mirabegron

NCT04550702 ·Status: COMPLETED